Amanote Research
Register
Sign In
Functional Genetic Polymorphisms in the Aromatase Gene CYP19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy With Aromatase Inhibitors
Breast Diseases
- United States
doi 10.1016/s1043-321x(10)79593-x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Surgery
Date
January 1, 2010
Authors
C.X. Ma
M.J. Ellis
Publisher
Elsevier BV
Related search
Genetic Variants of CYP19 (Aromatase) and Breast Cancer Risk
Oncogene
Cancer Research
Genetics
Molecular Biology
The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
An 8-Gene mRNA Expression Profile in Circulating Tumor Cells Predicts Response to Aromatase Inhibitors in Metastatic Breast Cancer Patients
BMC Cancer
Cancer Research
Oncology
Genetics
Prospective Characterization of Musculoskeletal Symptoms in Early Stage Breast Cancer Patients Treated With Aromatase Inhibitors
Breast Cancer Research and Treatment
Cancer Research
Oncology
Aromatase and COX in Breast Cancer: Enzyme Inhibitors and Beyond
Journal of Steroid Biochemistry and Molecular Biology
Molecular Medicine
Cell Biology
Molecular Biology
Biochemistry
Endocrinology
Clinical Biochemistry
Metabolism
Diabetes
Use of Aromatase Inhibitors in Breast Carcinoma
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Influence of CYP19A1 Polymorphisms on the Treatment of Breast Cancer With Aromatase Inhibitors: A Systematic Review and Meta-Analysis
BMC Medicine
Medicine
Molecular Characterization of Cytochrome P450 Aromatase (Cyp19) Gene in Egyptian River Buffaloes
Egyptian Journal of Genetics and Cytology
Estrone Sulphate, FSH, and Testosterone Levels in Two Male Breast Cancer Patients Treated With Aromatase Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
